Skip to main content
Frontiers in Bioengineering and Biotechnology logoLink to Frontiers in Bioengineering and Biotechnology
. 2021 Jun 28;9:686319. doi: 10.3389/fbioe.2021.686319

Evaluation of Heterologous Biosynthetic Pathways for Methanol-Based 5-Aminovalerate Production by Thermophilic Bacillus methanolicus

Luciana Fernandes Brito 1,, Marta Irla 1,, Ingemar Nærdal 2, Simone Balzer Le 2, Baudoin Delépine 3, Stéphanie Heux 3, Trygve Brautaset 1,*
PMCID: PMC8274714  PMID: 34262896

Abstract

The use of methanol as carbon source for biotechnological processes has recently attracted great interest due to its relatively low price, high abundance, high purity, and the fact that it is a non-food raw material. In this study, methanol-based production of 5-aminovalerate (5AVA) was established using recombinant Bacillus methanolicus strains. 5AVA is a building block of polyamides and a candidate to become the C5 platform chemical for the production of, among others, δ-valerolactam, 5-hydroxy-valerate, glutarate, and 1,5-pentanediol. In this study, we test five different 5AVA biosynthesis pathways, whereof two directly convert L-lysine to 5AVA and three use cadaverine as an intermediate. The conversion of L-lysine to 5AVA employs lysine 2-monooxygenase (DavB) and 5-aminovaleramidase (DavA), encoded by the well-known Pseudomonas putida cluster davBA, among others, or lysine α-oxidase (RaiP) in the presence of hydrogen peroxide. Cadaverine is converted either to γ-glutamine-cadaverine by glutamine synthetase (SpuI) or to 5-aminopentanal through activity of putrescine oxidase (Puo) or putrescine transaminase (PatA). Our efforts resulted in proof-of-concept 5AVA production from methanol at 50°C, enabled by two pathways out of the five tested with the highest titer of 0.02 g l–1. To our knowledge, this is the first report of 5AVA production from methanol in methylotrophic bacteria, and the recombinant strains and knowledge generated should represent a valuable basis for further improved 5AVA production from methanol.

Keywords: Bacillus methanolicus, thermophile, methanol, 5-aminovalerate, alternative feedstock

Introduction

The worldwide amino acid market is progressively growing at 5.6% annual rate and is estimated to reach US$25.6 billion by 2022, with amino acids used for animal feed production being its largest component (Wendisch, 2020). The growing demand for amino acid supply confronts the biotechnological industry with an unprecedented challenge of identifying suitable feedstocks, especially in terms of replacing sugars and agricultural products, use whereof deteriorates food supply and threatens biodiversity (Cotton et al., 2020). Methanol, together with other one-carbon (C1) compounds, is considered a very promising substitute for feedstock that are conventionally used in biotechnological processes. The major advantages of using methanol as carbon source are its low production cost (e.g., methanol from steam reforming of methane), ease of transport and storage, and complete miscibility that bypasses the mass transfer barrier and potentially supports improvement in microbial productivities. However, what seems to cause a considerable difficulty in propagation of methanol as biotechnological feedstock is the limited selection of microorganisms capable to be used as their carbon and energy source. One of the compelling candidates to become a workhorse for the methanol-based production of amino acids is Bacillus methanolicus, a thermophilic methylotroph isolated from freshwater marsh soil by Schendel et al. (1990). The wild-type strain MGA3 naturally overproduces L-glutamate in methanol-controlled fed-batch fermentations with volumetric titers reaching up to 60 g l–1 (Heggeset et al., 2012; Table 1). Furthermore, thanks to recent developments in the toolbox for gene overexpression, it was engineered for production of different amino acid derivatives such as γ-aminobutyric acid and cadaverine (Nærdal et al., 2015; Irla et al., 2017; Table 1). MGA3 produces 0.4 g l–1 of L-lysine in high cell density fed-batch fermentations (Brautaset et al., 2010; Table 1); this titer was improved nearly 30-fold up to 11 g l–1 by plasmid-based overexpression of a gene coding for aspartokinase, a key enzyme controlling the synthesis of aspartate-derived amino acids (Jakobsen et al., 2009). Through application of a classical mutagenesis technique, a derivative of B. methanolicus MGA3 (M168-20) was constructed, which produces 11 g l–1 of L-lysine in high cell density methanol-controlled fed-batch fermentations (Brautaset et al., 2010); the L-lysine overproduction being caused among others by mutation in the hom-1 gene coding for homoserine dehydrogenase (Hom) and in the putative lysine 2,3-aminomutase gene (locus tag BMMGA3_02505). The mutation in hom-1 leads to the loss of catalytic activity of homoserine dehydrogenase and redirection of metabolic flux toward the L-lysine pathway and therefore its accumulation (Nærdal et al., 2011, 2017).

TABLE 1.

Comparison of the 5AVA production by different engineered microbial strains and production of amino acids by B. methanolicus.

Organism Approach 5AVA titer [g l1] References
Pseudomonas putida KT2440 DavBA-based biocatalytic production of 5AVA from 30 g l–1 L-lysine 20.80 Liu et al., 2014
Corynebacterium glutamicum Heterologous expression of davBA; sugar-based fed-batch fermentation 33.10 Shin et al., 2016
28.00 Rohles et al., 2016
39.93 Joo et al., 2017
Heterologous expression of ldcC and patAD; shake flask fermentation 5.10 Jorge et al., 2017
Heterologous expression of puo and patD, deletion of gabTD; microbioreactor fermentation 3.70 Haupka et al., 2020
Escherichia coli Heterologous expression of davBA and deletion of cadA; glucose-based shaking flasks fermentation 0.86 Adkins et al., 2013
Heterologous expression of davBA; sugar-based fermentation; 10 g l–1 lysine provided 3.60 Park et al., 2013
Heterologous expression of davBA; sugar-based fed-batch fermentation 0.50 Park et al., 2013
Heterologous expression of davBA; glucose-based fed- batch fermentation; 120 g l–1 L-lysine provided 90.59 Park et al., 2014
Heterologous expression of davBA; fed-batch whole-cell bioconversion of L-lysine maintained at 120 g l–1 240.70 Wang et al., 2016
Heterologous expression of raiP; whole-cell bioconversion; addition of 4% ethanol, 10 mM H2O2 and 100 g l–1 lysine 29.12 Cheng et al., 2018
Heterologous expression of raiP; whole-cell bioconversion; 4% ethanol pretreatment, 10 mM H2O2 and 100 g l–1 lysine 50.62 Cheng et al., 2020

Organism Product in methanol-controlled fed-batch fermentation Titer [g L1] References

Bacillus methanolicus L-Glutamate 60.00 Heggeset et al., 2012
L-Lysine 11.00 Brautaset et al., 2010
γ-Aminobutyric acid 9.00 Irla et al., 2017
Cadaverine 11.30 Nærdal et al., 2015

5-Aminovalerate (5AVA) is a product of L-lysine degradation, and it is mainly synthesized in a two-step process catalyzed by a lysine monooxygenase (DavB) and a δ-aminovaleramide amidohydrolase (DavA) (Revelles et al., 2005). 5AVA is a non-proteogenic five-carbon amino acid that could potentially be used as building block for producing biobased polyamides (Adkins et al., 2013; Park et al., 2014; Wendisch et al., 2018). It is also a promising precursor for plasticizers and chemicals that are intermediates for bioplastic preparation: δ-valerolactam (Chae et al., 2017), 5-hydroxy-valerate (Sohn et al., 2021), glutarate (Adkins et al., 2013; Pérez-García et al., 2018), and 1,5-pentanediol (Cen et al., 2021). As summarized in Table 1, diverse approaches have been made at the establishment of microbial 5AVA production. Pseudomonas putida KT2440, which possesses davBA in its genome, can synthesize 20.8 g l–1 5AVA from 30 g l–1 L-lysine in 12 h (Liu et al., 2014). Production of 5AVA was established in Corynebacterium glutamicum by heterologous overexpression of the DavB- and DavA-encoding genes (davBA) from P. putida with a final titer up to 39.9 g l–1 in a sugar-based fed-batch fermentation (Rohles et al., 2016; Shin et al., 2016; Joo et al., 2017). 5AVA can be also produced in a process of bioconversion of L-lysine supplemented to the growth medium with molar yields of up to 0.942 achieved by Escherichia coli strains overproducing DavBA (Park et al., 2014; Wang et al., 2016). Moreover, when the recombinant E. coli strain expressing davAB genes was cultured in a medium containing 20 g l–1 glucose and 10 g l–1 L-lysine, 3.6 g l–1 5AVA was produced, representing a molar yield of 0.45 (Park et al., 2013). Disruption of native lysine decarboxylase (CadA and LdcC) activity in E. coli strains overexpressing davBA limited cadaverine by-product formation, enabling increased accumulation of L-lysine following 5AVA production, with 5AVA yield of 0.86 g l–1 in glucose-based shaking flask fermentation (Adkins et al., 2013). Furthermore, Cheng et al. (2018) reported that the oxidative decarboxylation of L-lysine catalyzed by a L-lysine α-oxidase (RaiP) from Scomber japonicus led to 5AVA production. The production of RaiP was enhanced by the addition of 4% (v/v) ethanol and 10 mM H2O2, which increased the 5AVA titer to 29.12 g l–1 by an E. coli host strain in a fed-batch fermentation (Cheng et al., 2018). Recently, in a similar L-lysine bioconversion strategy, an E. coli whole-cell catalyst producing RaiP was developed, converting 100 g l–1 of L-lysine hydrochloride to 50.62 g l–1 5AVA representing a molar yield of 0.84 (Cheng et al., 2020).

Recent efforts have employed novel metabolic routes toward 5AVA. In Pseudomonas aeruginosa PAO1, the set of enzymes composed of glutamylpolyamine synthetase, polyamine:pyruvate transaminase, aldehyde dehydrogenase, and glutamine amidotransferase is essential for the degradation of diamines through the γ-glutamylation pathway (Yao et al., 2011), which may lead to 5AVA production when cadaverine is degraded (Luengo and Olivera, 2020). Jorge et al. (2017) established a three-step 5AVA biosynthesis pathway consisting of the conversion of L-lysine to cadaverine by the activity of the enzyme LdcC, followed by cadaverine conversion to 5AVA through consecutive transamination, by a putrescine transaminase (PatA), and oxidation by a PatD. The heterologous overexpression of the genes ldcC, patA, and patD led to 5AVA production to a final titer of 5.1 g l–1 by an engineered C. glutamicum strain in a shake flask fermentation (Jorge et al., 2017). This pathway has served as basis for the establishment of a new three-step pathway toward 5AVA using the monooxygenase putrescine oxidase (Puo), which catalyzes the oxidative deamination of cadaverine, instead of PatA (Haupka et al., 2020).

Critical factors that can affect 5AVA accumulation in a production host are the presence of a native 5AVA degradation pathway in its genome and the end product-related inhibition. In some bacterial species, such as P. putida KT2440, Pseudomonas syringae, Pseudomonas stutzeri, and C. glutamicum, 5AVA is degraded by a GABAse (Figure 1), composed of two enzymes γ-aminobutyric acid aminotransferase (GabT) and succinic semialdehyde dehydrogenase (GabD) (Park et al., 2013; Rohles et al., 2016; Pérez-García et al., 2018); for example, GABAse from Pseudomonas fluorescens KCCM 12537 retains 47.7% activity when 5AVA is used as its substrate in comparison to when GABA is used (So et al., 2013). Based on the previous research, B. methanolicus seems a feasible candidate for 5AVA production because it does not possess the necessary genetic background for GABAse-based 5AVA degradation, lacking the gabT gene in its genome (Irla et al., 2017). It was reported that 5AVA does not supports growth of B. methanolicus neither as sole carbon source nor as sole nitrogen source (Haupka et al., 2021). However, B. methanolicus displays low tolerance to 5AVA, with growth being impaired by addition of 1.17 g l–1 5AVA to the culture broth (Haupka et al., 2021).

FIGURE 1.

FIGURE 1

Schematic view of five 5AVA biosynthesis pathways and a 5AVA degradation pathway. Five different pathways for potential 5AVA production in Bacillus methanolicus were tested; two pathways have L-lysine as precursor, and three pathways have cadaverine as an intermediate metabolite, obtained by conversion of L-lysine by a lysine decarboxylase (CadA). (A) DavBA pathway: L-lysine conversion to 5AVA by lysine 2-monooxygenase (DavB) and 5-aminovaleramidase (DavA). (B) RaiP pathway: conversion of L-lysine to α-ketolysine by a L-lysine α-oxidase (RaiP) and spontaneous decarboxylation of α-ketolysine in the presence of hydrogen peroxide. (C) SpuI pathway: cadaverine to γ-glutamine-cadaverine (γ-glu-cadaverine) by glutamylpolyamine synthetase (SpuI), with subsequent activity of polyamine:pyruvate transaminase (SpuC), aldehyde dehydrogenase (KauB), and glutamine amidotransferase class I (PauD2); γ-glu-aminopentanal: γ-glutamine-aminopentanal, γ-glu-aminovalerate: γ-glutamine-aminovalerate. (D) PatA pathway: cadaverine to 5-aminopentanal through activity of putrescine aminase (PatA) and 5-aminopentanal conversion to 5AVA by 5-aminopentanal dehydrogenase (PatD). (E) Puo pathway: cadaverine to 5-aminopentanal through activity of putrescine oxidase (Puo), followed by 5AVA formation by PatD. 5AVA is degraded to glutarate by GABAse activity, a combination of γ-aminobutyrate aminotransferase (GabT) and succinate semialdehyde dehydrogenase (GabD), although this activity was not found in B. methanolicus (Irla et al., 2017).

Even though the application of diverse 5AVA biosynthetic pathways has led to significant improvement in titers and yields of 5AVA production in bacterial hosts, the most efficient processes rely on raw materials that contain sugar and/or agricultural products. Addressing shortages of global resources and food requires a replacement of the current mode of industrial biotechnology, which results in the need for novel biosynthetic pathways that utilize alternative raw materials such as methanol. Hence, in the present study we have selected five different pathways to establish methanol-based 5AVA production in the methylotrophic bacterium B. methanolicus. For two of the five pathways, proof-of-principle 5AVA production was achieved and our results should represent a valuable basis of knowledge and strains for further improved 5AVA production from methanol at 50°C.

Materials and Methods

Retrosynthesis Analysis

Retrosynthesis analysis was conducted with RetroPath 2 (Delépine et al., 2018) (v6) and RetroRules (Duigou et al., 2019) (1.0.2, with hydrogens, in reversed direction) that translated reactions from MetaNetX (Moretti et al., 2016) into reaction rules, and KNIME (3.6.1). The “source” used in this analysis was 5AVA [InChI = 1S/C5H11NO2/c6-4-2-1-3-5(7)8/h1-4,6H2,(H,7,8)], and “sink” was the set of all metabolites from E. coli genome-scale model iJO1366 (Orth et al., 2011). We used at most four reaction steps and a diameter of eight chemical bonds around the reaction center. Those conservative parameters were used to limit the strength of the substrate promiscuity hypothesis and to limit our results to pathways most likely to compete with known pathways.

Strains, Genomic DNA, Plasmids, and Primers

Bacterial strains and plasmids used in this study are listed in Table 2. The E. coli strain DH5α was used as general cloning host, and B. methanolicus strains MGA3 and M168-20 were used as expression hosts. The following strains were the source of genetic material for cloning of the 5AVA synthesis pathways: E. coli MG1655, Rhodococcus qingshengii DSM45257, Paenarthrobacter aurescens DSM20116, Kocuria rosea DSM20447, Peribacillus simplex DSM1321, and P. putida KT2440. The L-lysine-α-oxidase-coding regions from Trichoderma viride (GenBank AB937978.1) and S. japonicus (GenBank AB970726.1) were codon-optimized for B. methanolicus MGA3 expression and synthesized by Twist Biosciences (Supplementary Table S1 and Supplementary Material). The davBA operons from alternative hosts Williamsia sterculiae CPCC 203464, Roseobacter denitrificans OCh 114 strain DSM 7001, and Parageobacillus caldoxylosilyticus B4119 (davA only) were codon-optimized for expression in B. methanolicus, synthesized and provided in the pUC57 plasmid from GenScript (Supplementary Table S1 and Supplementary Material). Isolated genomic DNA of Bacillus megaterium DSM32 was purchased from German Collection of Microorganisms and Cell Cultures GmbH (DSMZ). All primers (Sigma-Aldrich) used in this research are listed in Table 2.

TABLE 2.

Bacterial strains, plasmids, and primers used in this study.

Strain name Relevant characteristics References
Escherichia coli DH5α General cloning host, F-thi-1 endA1 hsdR17(r-,m-) supE44 _lacU169 (_80lacZ_M15) recA1 gyrA96 relA1 StrataGene
E. coli MG1655 Wild-type strain ATCC 47076
Bacillus methanolicus MGA3 Wild-type strain ATCC 53907
Bacillus methanolicus M160-20 1st-generation S-(2-aminoethyl) cysteine-resistant mutant of MGA3; L-lysine overproducer Brautaset et al., 2010
Rhodococcus qingshengii DSM45257 Wild-type strain DSM45257
Paenarthrobacter aurescens DSM20116 Wild-type strain DSM20116
Kocuria rosea DSM20447 Wild-type strain DSM20447
Peribacillus simplex DSM1321 Wild-type strain DSM1321
Pseudomonas putida KT2440 Wild-type strain DSM6125

Genomic DNA Relevant characteristics References

Bacillus megaterium DSM32 Wild-type strain DSM32

Plasmid Relevant characteristics References

pBV2xp KanR; derivative of pHCMC04 for gene expression under control of the xylose-inducible promoter. Drejer et al., 2020
pTH1mp CmR; derivative of pTH1mp-lysC for gene expression under control of the mdh promoter. The lysC gene was replaced with multiple cloning site. Irla et al., 2016
pMI2mp CmR; Low copy number derivative (in E. coli) of pTH1mp Drejer et al., 2020
pBV2xp-davBAPp KanR; pBV2xp derivative for expression of the P. putida davBA operon under control of the xylose-inducible promoter. This study
pBV2xp-davBAWs KanR; pBV2xp derivative for expression of the W. sterculiae davBA operon under control of the inducible xylose-inducible ose promoter. This study
pBV2xp-davBARd KanR; pBV2xp derivative for expression of the R. denitrificans davBA operon under control of the xylose-inducible promoter. This study
pBV2xp-davBWs-davAPc KanR; pBV2xp derivative for expression of the synthetic operon containing davB from W. sterculiae and davA from P. caldoxylosilyticus. Expression under control of the xylose-inducible promoter. This study
pBV2xp-davAPc-davBRd KanR; pBV2xp derivative for expression of the synthetic operon containing davA from P. caldoxylosilyticus and davB from R. denitrificans. Expression under control of the xylose-inducible promoter. This study
pBV2xp-davBPp KanR; pBV2xp derivative for expression of the P. putida davB gene under control of the xylose-inducible promoter. This study
pBV2xp-davBWs KanR; pBV2xp derivative for expression of the W. sterculiae davB gene under control of the xylose-inducible promoter. This study
pMI2mp-davAPc CmR; Derivative of pMI2mp for expression of P. caldoxylosilyticus davA gene under control of the constitutive mdh promoter. This study
pMI2mp-davAPp CmR; Derivative of pMI2mp for expression of P. putida davA gene under control of the constitutive mdh promoter. This study
pBV2xp-raiPPs KanR; pBV2xp-derived expression of raiP gene from P. simplex, under control of the xylose-inducible promoter This study
pBV2xp-raiPSj KanR; pBV2xp-derived expression of codon-optimized raiP gene from S. japonicus, under control of the xylose-inducible promoter This study
pBV2xp-raiPTv KanR; pBV2xp-derived expression of codon-optimized raiP gene from T. viride, under control of the xylose-inducible promoter This study
pTH1mp-cadA CmR; Derivative of pTH1mp for expression of E. coli MG1655-derived cadA gene under control of the constitutive mdh promoter. Nærdal et al., 2015
pTH1mp-katA CmR; Derivative of pTH1mp for expression of B. methanolicus-derived katA gene under control of the constitutive mdh promoter. This study
pBV2xp-AVAEc KanR; pBV2xp derivative for expression of the E. coli MG1655-derived genes patDA under control of the xylose-inducible promoter. This study
pBV2xp-AVABm KanR; pBV2xp derivative for expression of the B. megaterium DSM32-derived genes patDA under control of the xylose-inducible promoter. This study
pBV2xp-AVAPp KanR; pBV2xp derivative for expression of P. putida KT2440-derived spuI, spuC, kauB, and pauD2 genes under control of the xylose-inducible promoter. This study
pBV2xp-AVARq KanR; pBV2xp derivative for expression of the R. qingshengii DSM45257-derived puo and E. coli MG1655-derived patD genes under control of the xylose-inducible promoter. This study
pBV2xp-AVAPa KanR; pBV2xp derivative for expression of the P. aurescens DSM20116-derived puo and E. coli MG1655-derived patD genes under control of the xylose-inducible promoter. This study
pBV2xp-AVAKr KanR; pBV2xp derivative for expression of the K. rosea DSM20447-derived puo and E. coli MG1655-derived patD genes under control of the xylose-inducible promoter. This study

Primer Sequence 5′ → 3′ Characteristics

davBA_Pp_F1 atagttgatggataaacttgttcacttaaggaggtagtacatatgaacaagaagaaccgcc davBA from P. putida; fw
davBA_Pp_R1 aacgacggccagtgaattcgagctcactagttatcagcctttacgcaggtg davBA from P. putida; rv
davB_Pp_F1 gatggataaacttgttcacttaagg davB from P. putida for pBV2xp-davBPp; fw
davB_Pp_R1 acggccagtgaattcgagctcaatccgccagggcgatc davB from P. putida for pBV2xp-davBPp; rv
davA_Pc_F1 ccagattagcatttaaactagttttgtaaacaattacataaataggaggtagtacatatggaaacatcatatgaaattgcac davA from P. caldoxylosilyticus for pMI2mp-davAPc; fw
davA_Pc_R1 tctagacctatggcgggtaccttaataaacatctgttcttctttcattcatc davA from P. caldoxylosilyticus for pMI2mp-davAPc; rv
davB_Ws_F1 ggataaacttgttcacttaaggaggtagtacatatgagagttacaacatcagttgg davB from W. sterculiae for pBV2xp-davBWs; fw
davB_Ws_R1 acggccagtgaattcgagctcttataatccaatatcaagtggtcc davB from W. sterculiae for pBV2xp-davBWs; rv
davA_Pp_F1 ccagattagcatttaaactagttttgtaaacaattacataaataggaggtagtacatatgcgcatcgctctgtacc dava from P. putida for pMI2mp-davaPp; fw
davA_Pp_R1 tctagacctatggcgggtacctcagcctttacgcaggtgc dava from P. putida for pMI2mp-davaPp; rv
raippsfw cttgttcacttaagggggaaatggctatgctcgctgtgatcagaaatggccttgg raiP from P. simplex fw
raippsrv gccagtgaattcgagctcatggtacggatcttaaaaaggctcactcaatgttctaggc raiP from P. simplex rv
raipsjfw cttgttcacttaagggggaaatggctatggaacatttagcagattgtttagaag raiP from S. japonicus fw
raipsjrv gccagtgaattcgagctcatggtacggatcttataattcatcttttgtatgttcaattg raiP from S. japonicus rv
raiptvfw cttgttcacttaagggggaaatggctatggataatgttgattttgcagaatctg raiP from T. viride fw
raiptvrv gccagtgaattcgagctcatggtacggatcttaaattttaacttgatattcttttgg raiP from P. viride rv
Katafw gtaaacaattacataaataggaggtagtagtacatgaccacaaataagaaaaaacttactacaagc katA from B. methanolicus fw
katarv ggatccccgggaattcaagctttaaacatgttaaactttcttttgtacaggtaaacctagac katA from B. methanolicus rv
AVA1 ttcacttaagggggaaatggcaaatggatcgtacagtcgttaaaa patDA from B. megaterium; fw
AVA2 acgacggccagtgaattcgagctttattggtggttcagctcatt patDA from B. megaterium; fw
AVA3 ttcacttaagggggaaatggcaaatgtcggtacccccgcgtgccgttcagcttaac spuI from P. putida; fw
AVA4 ttacacggtatgcaggtaccag spuI from P. putida; rv
AVA5 tggtacctgcataccgtgtaatacataaataggaggtagtaagaatgagcgtcaacaacccgcaaacccgtgaatg spuC from P. putida; fw
AVA6 ttattgaatcgcctcaagggtcaggtccag spuC from P. putida; rv
AVA7 acccttgaggcgattcaataatacataaataggaggtagtaagaatgaccaccctgacccgtgcggactgggaacaa kauB from P. putida; fw
AVA8 ttacagcttgatccaggtcgccttcagctcgg kauB from P. putida; rv
AVA9 cgacctggatcaagctgtaatacataaataggaggtagtaagaatgtcgttacgcatctgcatcc pauD2 from P. putida; fw
AVA10 acgacggccagtgaattcgagctttacgcggcgctgtcgccggcctttga pauD2 from P. putida; rv
AVA11 ttcacttaagggggaaatggcaaatgcaacataagttactgattaacggagaactggttag patD from E. coli; fw
AVA12 ttaatgtttaaccatgacgtggcggacga patD from E. coli; rv
AVA13 cacgtcatggttaaacattaatacataaataggaggtagtaagaatgaacaggttaccttcgagcgcatcggctttag patA from E. coli; fw
AVA14 acgacggccagtgaattcgagctttacgcttcttcgacacttactcgcatgg patA from E. coli; rv
AVA23 ttcacttaagggggaaatggcaaatgaacctaattcattttagtgtgaagg puo from Kocuria rosea; fw
AVA29 tcttactacctcctatttatgtaattgtttactcatcgctccgcgcccgtca puo from Kocuria rosea; rw
AVA25 ttcacttaagggggaaatggcaaatgcagaatcttgatcgcgacgttgtgatcgtcgg puo from P. aurescens; fw
AVA30 tcttactacctcctatttatgtaattgtttactcaggcgacaggtacagaagccaacttgtt puo from P. aurescens; rv
AVA27 ttcacttaagggggaaatggcaaatgcctactctccagagagacgttgcaatcgt puo from R. qingshengii; fw
AVA31 tcttactacctcctatttatgtaattgtttactcaggccttgctgcgagcgatgatgt puo from R. qingshengii; rv
AVA32 gtaaacaattacataaataggaggtagtaagaatgcaacataagttactgattaacggagaactggttag patD from E. coli (for puo-patD); fw
AVA33 acgacggccagtgaattcgagctttaatgtttaaccatgacgtggcggacga patD from E. coli (for puo-patD); rv
MI09 gataccaaatactgtccttctagtgtagccg SDM of ori pUC9; fw
MI10 cggctacactagaaggacagtatttggtatc SDM of ori pUC9; rv

CmR, chloramphenicol resistance; KanR, kanamycin resistance.

Molecular Cloning

The E. coli DH5α competent cells were prepared according to the calcium chloride protocol as described in Green and Rogers (2013) or purchased as chemically competent NEB 5-α E. coli cells (New England Biolabs). All standard molecular cloning procedures were carried out as described in Sambrook and Russell (2001) or according to manuals provided by producers. Chromosomal DNA was isolated as described in Eikmanns et al. (1994). PCR products were amplified using CloneAmp HiFi PCR Premix (Takara) and purified using a QIAquick PCR Purification Kit from Qiagen. DNA fragments were separated using 8 g l–1 SeaKem LE Agarose gels (Lonza) and isolated using a QIAquick Gel Extraction Kit (Qiagen). The colony PCR was performed using GoTaq DNA Polymerase (Promega). The sequences of cloned DNA fragments were confirmed by Sanger sequencing (Eurofins). B. methanolicus MGA3 was made electrocompetent and transformed by electroporation as described previously (Jakobsen et al., 2006). Recombinant DNA was assembled in vitro by means of the isothermal DNA assembly method (Gibson et al., 2009), employing the NEBuilder HiFi DNA Assembly Kit or ligation with T4 DNA ligase. pMI2mp plasmid was obtained via site-directed mutagenesis (SDM) of pTH1mp performed as previously described with CloneAmp HiFi PCR Premix (Liu and Naismith, 2008). The detailed description of plasmid creation is presented in Supplementary Material.

Media and Conditions for Shake Flask Cultivations

E. coli and P. putida strains were cultivated at 37°C in Lysogeny Broth (LB) or on LB agar plates supplemented with antibiotics when necessary. P. aurescens DSM2011 and K. rosea DSM20447 were cultivated at 30°C and 225 rpm in medium 53 (casein peptone, tryptic digest, 10.0 g l–1, yeast extract, 5.0 g l–1, glucose, 5.0 g l–1, NaCl, 5.0 g l–1; pH adjusted to 7.2–7.4); R. qingshengii DSM45257 was grown at 28°C and 225 rpm in medium 65 (glucose, 4.0 g l–1, yeast extract, 4.0 g l–1, malt extract, 10.0 g l–1; adjusted to pH to 7.2); and P. simplex DSM1321 was cultivated in nutrient medium (peptone 5 g l–1 and meat extract 3 g l–1; pH adjusted to 7.0) at 30°C and 200 rpm. For preparation of crude extracts, electrocompetent cells and transformation B. methanolicus strains were cultured at 50°C in SOB medium (Difco) supplemented with antibiotics when necessary. For 5AVA production experiments, recombinant B. methanolicus strains were cultivated in 250-ml baffled shake flasks at 50°C and 200 rpm in 40 or 50 ml MVcM medium containing 200 mM methanol. The MVcM medium contained the following, in 1 l of distilled water: K2HPO4, 4.09 g; NaH2PO4H2O, 1.49 g; (NH4)2SO4, 2.11 g; it was adjusted to pH 7.2 before autoclaving. The MVcM medium was supplemented with 1 ml 1 M MgSO47H2O solution, 1 ml trace element solution, and 1 ml vitamin solution (Schendel et al., 1990). One mole of MgSO47H2O solution contained 246.47 g of MgSO47H2O in 1 l of distilled water. The trace element solution contained the following, in 1 l of distilled water: FeSO47H20, 5.56 g; CuSO42H2O, 27.28 mg; CaCl22H2O, 7.35 g; CoCl26H2O, 40.50 mg; MnCl24H2O, 9.90 g; ZnSO47H2O, 287.54 mg; Na2MoO42H2O, 48.40 mg; H3BO3, 30.92 mg; and HCl, 80 ml. The vitamin solution contained the following, in 1 l of distilled water: biotin, thiamine hydrochloride, riboflavin, D-calcium pantothenate, pyridoxine hydrochloride, nicotinamide, 0.1 g each; p-aminobenzoic acid, 0.02 g; folic acid, vitamin B12 and lipoic acid, 0.01 g each (Schendel et al., 1990). When needed, 10 g l–1 xylose (v/v) was added for induction. For precultures, a minimal medium supplemented with 0.25 g l–1 yeast extract, designated MVcMY, was used. Antibiotics (chloramphenicol, 5 μg ml–1 and/or kanamycin, 25 μg ml–1) were supplemented as necessary. Cultivations were performed in triplicates with start OD600 of 0.1–0.2. Growth was monitored by measuring OD600 with a cell density meter (WPA CO 8000 Biowave).

Determination of Amino Acid Concentration

For the analysis of amino acid concentrations, 1 ml of the culture sample was taken from the bacterial cultures and centrifuged for 10 min at 11,000 rpm. Extracellular amino acids were quantified by means of high-pressure liquid chromatography (HPLC, Waters Alliance e2695 Separations Module). The samples underwent FMOC-Cl (fluorenylmethyloxycarbonyl chloride) derivatization before the analysis, according to the protocol described before (Haas et al., 2014), and were separated on a column (Symmetry C18 Column, 100 Å, 3.5 μm, 4.6 mm × 75 mm, Waters) according to the gradient flow presented in Table 3, where A is an elution buffer 50 mM Na-acetate pH = 4.2 and B is an organic solvent, acetonitrile. The detection was performed with a Waters 2475 HPLC Multi Fluorescence Detector (Waters), with excitation at 265 nm and emission at 315 nm.

TABLE 3.

Determined parameters of mobile phase gradient conditions in a HPLC separation of FMOC-derivatized amino acids.

Program time [min] Flow rate [ml min–1] %A %B
1.3 62.0 38.0
5 1.3 62.0 38.0
12 1.3 43.0 57.0
14 1.3 24.0 76.0
15 1.3 43.0 57.0
18 1.3 620 38.0

Mobile phase consists of elution buffer 50 mM Na-acetate pH = 4.2 (A) and organic solvent acetonitrile (B).

Enzyme Assays

In order to determine enzymatic activity, crude extracts of recombinant B. methanolicus cells were prepared according to Drejer et al. (2020). B. methanolicus strains were inoculated in SOB medium and grown to exponential phase (OD600 = 0.8). Recombinant expression was induced by addition of 10 g l–1 xylose 2 h after inoculation. A total amount of 50 ml culture broth was harvested by centrifugation at 7,500 rpm and 4°C for 15 min and washed twice in ice-cold buffer used for specific enzyme assay before storing at −80°C. The cells were thawed in ice and disrupted by sonication using a Fisherbrand Sonic Dismembrator (FB-505) with 40% amplitude with 2 s on and 1 s off-pulse cycles for 7 min. Cell debris was then removed by centrifugation (at 14, 000 rpm and 4°C for 1 h). Protein concentrations were determined by Bradford assay (Bradford, 1976), using bovine albumin serum (Sigma) as standard.

L-Lysine α-oxidase activity was assayed by measuring the rate of hydrogen peroxide formation, as described elsewhere (Tani et al., 2015a). The reaction was initiated by adding crude extracts from B. methanolicus strains to the reaction media (50°C) consisting of 100 mM L-lysine and 50 mM pH 7 phosphate buffer, resulting in a total volume of 1 ml. Next, the sample was quenched by addition of 50 μl 2 M HCl. After neutralization with 50 μl 2 M NaOH, 200 μl of the mixture was withdrawn and transferred to 800 μl of a second reaction mixture containing 50 mM pH 6 phosphate buffer, 30 mM phenol, 2 units ml–1 peroxidase from horseradish (Sigma) and 0.5 mM 4-aminoantipyrine. Formation of quinoneimine dye from oxidative coupling of phenol and 4-aminoantipyrine (Job et al., 2002) was determined by measuring absorbance at 505 nm using a Cary 100 Bio UV-visible spectrophotometer (Varian). One unit (U) of RaiP activity was defined as the amount of enzyme that catalyzes the formation of 1 μmol hydrogen peroxide per minute.

Catalytic activities of PatA and PatD or putrescine oxidase and PatD were measured by using a coupled reaction, and cadaverine was used as substrate instead of putrescine, as previously described elsewhere, with modifications (Jorge et al., 2017). The 1-ml assay mix contained 0.1 M Tris–HCl pH 8.0, 1.5 mM α-ketoglutarate, 2.5 mM cadaverine, 0.1 mM pyridoxal-5′-phosphate, and 0.3 mM NAD. In this coupled reaction, cadaverine was converted to 5AVA via 5-aminopentanal and one unit of coupled enzyme activity was defined as the amount of the enzyme that formed 1 μmol of NADH (ε340 nm = 6.22 mM–1 cm–1) per minute at 50°C.

The coupled DavAB assay was performed as described in Liu et al. (2014) with some modifications. Five hundred microliters of crude extract was added into 50-ml Falcon tubes filled with 4 ml 100 mM phosphate buffer pH 7.0 supplemented with 10 g l–1 L-lysine. The tubes were incubated for 40 h at 30 or 50°C with stirring at 200 rpm. The samples for quantification of 5AVA concentration through HPLC (see section “Determination of Amino Acid Concentration”) were taken at the beginning of incubation, after 16 h and after 40 h.

Results and Discussion

Selection, Design, and Construction of Heterologous Biosynthetic Pathways for 5AVA Biosynthesis in B. methanolicus

Due to the fact that B. methanolicus is a thermophile, a typical issue concerning implementation of biosynthetic pathways from heterologous hosts is the lack of thermostability of the transferred enzymes. It was shown before that a screening of diverse donor organisms allows to identify pathways active at 50°C and leads to increased product titers (Irla et al., 2017; Drejer et al., 2020). In order to extend the scope of our screening, we have constructed 26 strains with five different 5AVA biosynthetic pathways, which are presented in Figure 1, derived from diverse donors. Two pathways that directly convert L-lysine to 5AVA were chosen: the DavBA pathway (Figure 1A) and the RaiP pathway (Figure 1B), as well as three pathways that use cadaverine as an intermediate: the SpuI pathway (Figure 1C), the PatA pathway (Figure 1D), and the Puo pathway (Figure 1E).

The genes encoding the core part of those pathways are cloned into a θ-replication, low copy number derivative of pHCMC04 plasmid, pBV2xp, under control of a B. megaterium-derived, xylose-inducible promoter, and the genes encoding any ancillary enzymes are cloned into pTH1mp or pMI2mp plasmids, which are compatible to pBV2xp, under control of the mdh promoter (Irla et al., 2016). The plasmids with genes encoding desired pathways were constructed as described fully in the Supplementary Material and then used to transform B. methanolicus cells leading to formation of strains presented in Table 4.

TABLE 4.

List of B. methanolicus strains used in this study with abbreviated strain names.

Abbreviated strain name Recombinant B. methanolicus strains created in this study
MGA3_EV MGA3(pBV2xp)
MGA3_DavBAPp MGA3(pBV2xp-davBAPp)
MGA3_DavBAWs MGA3(pBV2xp-davBAWs)
MGA3_DavBARd MGA3(pBV2xp-davBARd)
MGA3_DavBWsAPc MGA3(pBV2xp-davBWs-davAPc)
MGA3_DavAPcBRd MGA3(pBV2xp-davAPc-davBRd)
MGA3_DavBPpAPc(2p) MGA3(pMI2mp-davAPc)(pBV2xp-davBPp)
MGA3_DavBWsAPc(2p) MGA3(pMI2mp-davAPc)(pBV2xp-davBWs)
M168-20_EV M168-20(pBV2xp)
M168-20_DavBAPp M168-20(pBV2xp-davBAPp)
M168-20_DavAPpBPp(2p) M168-20(pMI2mp-davAPp)(pBV2xp-davBPp)
M168-20_DavAPpBWs(2p) M168-20(pMI2mp-davAPp)(pBV2xp-davBWs)
MGA3_RaiPPs MGA3(pBV2xp-raiPPs)
MGA3_RaiPSj MGA3(pBV2xp-raiPSj)
MGA3_RaiPTv MGA3(pBV2xp-raiPTv)
M168-20_RaiPPs M168-20 (pBV2xp-raiPPs)
M168-20_RaiPSj M168-20(pBV2xp-raiPSj)
M168-20_RaiPTv M168-20 (pBV2xp-raiPTv)
MGA3_Cad MGA3(pTH1mp-cadA)(pBV2xp)
MGA3_PatAEc MGA3(pTH1mp-cadA)(pBV2xp-AVAEc)
MGA3_PatABm MGA3(pTH1mp-cadA)(pBV2xp-AVABm)
MGA3_SpuI MGA3(pTH1mp-cadA)(pBV2xp-AVAPp)
MGA3_Kat MGA3(pTH1mp-katA)(pBV2xp)
MGA3_PuoKr MGA3(pTH1mp-katA)(pBV2xp-AVAKr)
MGA3_PuoPa MGA3(pTH1mp-katA)(pBV2xp AVAPa)
MGA3_PuoRq MGA3(pTH1mp-katA)(pBV2xp-AVARq)

With help of retrosynthesis analysis, we have considered two pathways that utilize L-lysine directly as precursor and that utilize either DavB (EC 1.13.12.2) and DavA (EC 3.5.1.30) activity (DavBA pathway, Figure 1A) or RaiP (EC 1.4.3.14) in the presence of H2O2 (RaiP pathway, Figure 1B) for further conversion into 5AVA. For DavBA production, three different davBA operons from the following mesophilic organisms were applied: P. putida, W. sterculiae, and R. denitrificans. We could not identify a complete davBA operon from a thermophilic host; however, thermophilic P. caldoxylosilyticus possesses a putative davA gene and was also included in this study. All selected davBA operons were codon-optimized and cloned into the pBV2xp vector under control of the xylose-inducible promoter as described in the Supplementary Material. The finished vectors were used to create the following B. methanolicus strains: MGA3_DavBAPp, MGA3_DavBAWs, MGA3_DavBARd, MGA3_DavBWsAPc, and MGA3_DavAPcBRd (Table 4). Furthermore, selected davBA operons were expressed as single genes using compatible pBV2xp and pMI2mp plasmids for gene expression (Supplementary Material). The davB genes from P. putida and W. sterculiae were cloned under control of the xylose-inducible promoter in plasmid pBV2xp, while the davA gene from P. caldoxylosilyticus was cloned into the pMI2mp plasmid under control of the mdh promoter constitutively active in methylotrophic conditions. The combination of two plasmids (2p) expressing single genes resulted in creation of the following B. methanolicus strains: MGA3_DavBPpAPc(2p) and MGA3_DavBWsAPc(2p) (Table 4).

For expression of the RaiP pathway, the B. methanolicus strains MGA3_RaiPPs, MGA3_RaiPSj, and MGA3_RaiPTv (Table 4) carried heterologous raiP gene sequences from the prokaryote P. simplex and from the eukaryotic genetic donors S. japonicus and T. viride, respectively, the two latter with characterized RaiP activity (Arinbasarova et al., 2012; Tani et al., 2015a). The full length of codon-optimized sequences derived from S. japonicus and T. viride is present in the Supplementary Table S1. The original S. japonicus sequence encodes a protein with 617 amino acids and has a 52.2% GC content, while the sequence codon optimized for B. methanolicus has a GC content of 29%. The T. viride-derivative sequence was adjusted from the GC content of 42.5 to 28.6%. The substitution of nucleotides did not alter their coding amino acid sequences.

Among the pathways using cadaverine formed from L-lysine through activity of E. coli-derived lysine decarboxylase CadA (EC 4.1.1.18, encoded by cadA) as an intermediate, we considered a multistep diamine catabolic pathway of P. aeruginosa PAOI (SpuI pathway, Figure 1C) (Yao et al., 2011). In order to test this pathway for methanol-based 5AVA production, the MGA3_SpuI strain was constructed through transformation of B. methanolicus wild type with two vectors pTH1mp-cadA and pBV2xp-AVAPp, the first one carrying the cadA gene and the latter the genes encoding the SpuI pathway (Table 4 and Supplementary Material). The SpuI pathway that converts cadaverine to 5AVA is composed of the following enzymes: glutamylpolyamine synthetase (EC 6.3.1.2, SpuI), polyamine:pyruvate transaminase (EC 2.6.1.113, SpuC), aldehyde dehydrogenase (EC 1.2.1.3, KauB), and glutamine amidotransferase class I (EC 6.3.5.2, PauD2) (Yao et al., 2011).

Another pathway, also predicted by our retrosynthesis analysis, potentially leading to production of 5AVA from L-lysine is a three-step pathway composed of CadA, PatA (EC 2.6.1.82, PatA), and 5-aminopentanal dehydrogenase (EC 1.2.1.19, PatD) (PatA pathway, Figure 1D). In order to test this pathway, two strains were constructed, MGA3_PatAEc and MGA3_PatABm, through transformation of B. methanolicus with pTH1mp-cadA plasmid, and pBV2xp-AVAEc or pBV2xp-AVABm, respectively (Table 4). As described in the Supplementary Material, the lysine decarboxylase-encoding gene (cadA) was placed under control of the mdh promoter in a rolling circle vector pTH1mp. The E. coli-derived patAD operon encoding previously characterized enzymes was placed under control of the xylose-inducible promoter in pBV2xp, resulting in pBV2xp-AVAEc (Samsonova et al., 2003). The genes of the patAD operon in B. megaterium were identified based on a BLAST search of its genome and were cloned into pBV2xp, yielding pBV2xp-AVABm (Altschul et al., 1990). While the existence of prior art makes it a solid candidate, we knew that its second step catalyzed by PatA may suffer from an unfavorable thermodynamic (predicted close to 0 kJ mol–1) (Noor et al., 2012).

In our study, we have also included a pathway confirmed through retrosynthesis analysis where the step of cadaverine transamination (PatA pathway, Figure 1D) is replaced by its oxidative deamination (Puo pathway, Figure 1E) because this reaction displays a more favorable thermodynamic (predicted close to −100 kl mol–1 in cell conditions) in comparison to PatA. While a cadaverine oxidase has not been identified before, it was shown that putrescine oxidase encoded by puo retains up to 14% of its maximal activity when cadaverine is used as a substrate (Okada et al., 1979; Ishizuka et al., 1993; van Hellemond et al., 2008; Lee and Kim, 2013). We have therefore decided to express three different versions of the puo gene derived from K. rosea, P. aurescens, and R. qingshengii, together with the E. coli-derived patD gene from the pBV2xp plasmid (for details see Supplementary Material), which led to creation of the following strains: MGA3_PuoKr, MGA3_PuoPa, and MGA3_PuoRq, respectively (Table 4). In order to prevent oxidative stress caused by H2O2 formation, a native gene encoding catalase was homologously expressed from pTH1mp plasmid in all constructed strains.

Testing Recombinant B. methanolicus Strains for 5AVA Production From Methanol

The plasmids designed and built as described in the above Section were used for transformation of wild-type B. methanolicus cells and resulted in the creation of 26 different strains (Table 4) which were then tested for their ability to synthetize 5AVA. All strains were cultivated in minimal medium supplemented with methanol as the sole carbon and energy source, and the 5AVA titer was evaluated after the strains had reached the stationary growth phase as described in the following sections.

Expression of the DavAB-Encoding Genes Resulted in no 5AVA Biosynthesis in B. methanolicus

In the first attempt, we heterologously expressed genes encoding the DavBA pathway in B. methanolicus MGA3 (Figure 1A). In addition to the well-known davBA operon from P. putida (gamma-proteobacteria), the alternative davBA operon from W. sterculiae (actinobacteria) and davAB from R. denitrificans (alpha-proteobacteria) were tested for 5AVA formation in B. methanolicus MGA3. Moreover, the only enzyme identified from a thermophilic host, DavA from P. caldoxylosilyticus (bacilli), was combined with the before mentioned lysine 2-monooxygenases (DavB). P. caldoxylosilyticus has a reported optimum growth temperature from 50 to 65°C (Fortina et al., 2001).

Several considerations were made with regard to strain design, namely, adjusting the GC content and the types of codons present in the open reading frames in the genomic DNA of a donor and designing suitable expression cassettes. In total, seven different B. methanolicus strains were constructed: MGA3(pBV2xp-davBAPp) named MGA3_DavBAPp, MGA3(pBV2xp-davBAWs) named MGA3_DavBAWs, MGA3(pBV2xp-davBARd) named MGA3_DavBARd, MGA3(pBV2xp-davBWs-davAPc) named MGA3_DavBWsAPc, MGA3(pBV2xp-davAPc-davBRd) named MGA3_DavAPcBRd, MGA3(pMI2mp-davAPc)(pBV2xp-davBPp) named MGA3_DavBPpAPc(2p), MGA3(pMI2mp-davAPc) (pBV2xp-davBWs) named MGA3_DavBWsAPc(2p) (Table 4). However, in none of the tested strains (MGA3_DavBAPp, MGA3_DavBAWs, MGA3_DavBARd, MGA3_DavBWsAPc, MGA3_DavAPcBRd), the active pathway was expressed; and followingly no 5AVA accumulation was observed during shake flask cultivations in any constructed strain (data not shown). The first reaction step from L-lysine to 5-aminopentanamide requires O2 (Figure 1A), and due to the high O2 demand to facilitate the assimilation of methanol, we also tested 5AVA formation from the alternative carbon source mannitol. Neither was this strategy successful. Furthermore, the DavAB pathway was also tested in the genetic background of L-lysine-overproducing B. methanolicus strain M160-20. Specifically, the following strains were constructed: M168-20_DavBAPp, M168-20_DavAPpBPp(2p), and M168-20_DavAPpBWs(2p); however, none of them produced any detectable 5AVA (data not shown). Taken together, the DavBA pathway did not enable 5AVA formation. It is not clear whether this was caused by low enzymatic stability at 50°C (only P. caldoxylosilyticus is known to be thermophilic among the organisms found to be source organisms for the two genes). In order to exclude the effect of elevated temperature on the DavAB activity, we tested enzymatic activity at 30°C for selected strains (MGA3_DavBAPp, MGA3_DavBAWs, MGA3_DavBARd, MGA3_DavBWsAPc, and MGA3_DavAPcBRd); however, no DavAB activity was detected (data not shown). The reason why the functional DavAB pathway was not expressed in B. methanolicus remains unknown.

RaiP Pathway Is Functional in B. methanolicus and Supports 5AVA Production

Methanol-based 5AVA biosynthesis was attempted via heterologous expression of RaiP encoding gene raiP in MGA3. The strains MGA3(pBV2xp-raiPPs) named MGA3_RaiPPs, MGA3(pBV2xp-raiPSj) named MGA3_RaiPSj, and MGA3(pBV2xp-raiPTv) named MGA3_RaiPTv (Table 4) carry the raiP gene from the bacterium P. simplex and raiP genes with codon-optimized sequences from the eukaryotic donors S. japonicus and T. viride, respectively. The T. viride-derived RaiP was shown to be stable at temperatures up to 50°C (Arinbasarova et al., 2012). It is reported that the RaiP protein from S. japonicus is thermally stable for at least 1 h in temperatures up to 60°C, with its highest activity registered at 70°C (Tani et al., 2015b). Moreover, although there is no kinetic characterization of RaiP from P. simplex available, this bacterium is classified as mesophilic, with growth optimum at 30°C (Yumoto et al., 2004). To examine the activity of RaiP in the constructed B. methanolicus strains, L-lysine α-oxidase activity was measured at 50°C. While the empty vector control strain has shown no RaiP activity, the highest RaiP specific activity was observed in crude extracts from strain MGA3_RaiPTv, being 62.1 ± 1.4 mU mg–1 (Figure 2A). The values of RaiP activity for strains MGA3_RaiPPs and MGA3_RaiPSj were 1.4 ± 0.3 mU mg–1 and 12.0 ± 4.4 mU mg–1, respectively (Figure 2A). It is not clear if the poor activity of heterologous RaiP from genetic donors S. japonicus and P. simplex was caused by low enzymatic stability at 50°C, and the reason for that remains to be investigated.

FIGURE 2.

FIGURE 2

Evaluation of RaiP enzyme activity (A) and amino acids production (B) in recombinant B. methanolicus strains. B. methanolicus strains MGA3_EV, MGA3_RaiPSj, MGA3_RaiPPs, or MGA3_RaiPTv were cultivated in a shaking flask culture. The grown cells were harvested, washed twice with 50 mM phosphate buffer (pH 7.0), and disrupted by sonication. After centrifugation, the crude extracts were directly used for the RaiP assay. MGA3_EV and MGA3_RaiPTv were cultivated for 27 h, and supernatants were obtained by centrifugation for HPLC analysis. The error bars represent standard deviation of technical triplicates.

HPLC analysis of supernatant from MGA3_RaiPTv strain cultivated in minimal medium revealed 16.15 ± 1.62 mg L–1 5AVA and 0.27 ± 0.04 mg L–1 L-lysine. In contrast, the L-lysine level in the MGA3 strain harboring the empty vector plasmid pBV2xp (MGA3_EV) was 37.8 ± 7.2 mg L–1 (Figure 2B). Even though a slight RaiP activity was observed in crude extract of the strains MGA3_RaiPPs and MGA3_RaiPSj, no 5AVA production was observed for those strains (data not shown). Let us note here that the 5AVA titer in the methanol-based shaking flask fermentation of strain MGA3_RaiPTv was significantly inferior to that in previously reported glucose-based fermentations in E. coli (Cheng et al., 2018).

The value of the Michaelis–Menten constant for T. viride-derived RaiP for L-lysine has been estimated (Km = 5.85 mg L–1) (Kusakabe et al., 1980). Therefore, the precursor levels in the B. methanolicus strains should not be a limiting factor for production of 5AVA. The RaiP-mediated production is mainly utilized in the L-lysine bioconversion approach, utilizing E. coli strains as whole-cell biocatalysts (Cheng et al., 2018, 2020, 2021) where high concentrations of the precursor were used; for example, the molar yield of 0.942 was obtained from 120 g l–1 L-lysine (Park et al., 2014). However, construction and testing of the B. methanolicus strains M168-20_RaiPSj, M168-20_RaiPPs, and M168-20_RaiPTv (Table 4), based on the L-lysine-over producing mutant M168-20 (Brautaset et al., 2010), did not result in any improved 5AVA production (data not shown).

The lack of 5AVA production in MGA3_RaiPPs and MGA3_RaiPSj, as well as low 5AVA titer produced by strain MGA3_RaiPTv, might be related to the spontaneous conversion step that follows RaiP activity. This could be a limiting factor for the RaiP-mediated production of 5AVA. Three compounds are produced in a reaction catalyzed by RaiP: α-ketolysine, NH3, and H2O2 (Mai-Prochnow et al., 2008; Cheng et al., 2018). In a second spontaneous step of 5AVA synthesis, the intermediate α-ketolysine is oxidatively decarboxylated to form 5AVA in the presence of H2O2 as an oxidizing agent. It was shown that the addition of H2O2 into the culture broth has led to an 18−fold increase of 5AVA titers in comparison with the control condition without H2O2 (final titer 29.12 g l–1) in a 5–l fermenter (Cheng et al., 2018). The RaiP-mediated 5AVA production may be increased by enzymatic conversion of α-ketolysine in an approach different to ours, where spontaneous reaction of oxidative decarboxylation occurs. Recently, an artificial synthetic pathway for the biosynthesis of 5AVA in E. coli was developed, consisting of three steps: conversion of L-lysine to α-ketolysine via RaiP, decarboxylation of α-ketolysine to produce 5-aminopentanal via α-ketoacid decarboxylase, and oxidation of 5-aminopentanal to 5AVA via aldehyde dehydrogenase. The expression of the artificial pathway resulted in a yield increase of 774% compared to the single gene pathway (Cheng et al., 2021). This approach is potentially a feasible strategy we have shown in our study that E. coli-derived PatD is active as a 5-aminopentanal dehydrogenase in B. methanolicus and participates in 5AVA biosynthesis (see Section “The PatA Pathway Supports 5AVA Accumulation in B. methanolicus).

Use of the SpuI Pathway Does Not Lead to 5AVA Production in B. methanolicus

Three different pathways that use cadaverine as an intermediate product have been tested for their feasibility for production of 5AVA in B. methanolicus. Cadaverine biosynthesis in B. methanolicus cells was enabled through the activity of lysine decarboxylase encoded by a heterologously expressed cadA (Nærdal et al., 2015). Cadaverine can be converted to 5AVA through activity of a multistep diamine catabolic pathway derived from P. aeruginosa PAOI (SpuI pathway, Figure 1C) (Yao et al., 2011). The MGA3(pTH1mp-cadA)(pBV2xp-AVAPp) strain called MGA3_SpuI (Table 4) did not accumulate any 5AVA during methanol-based growth in minimal medium, despite the accumulation of the precursor, cadaverine, at the level of 118.8 ± 5.1 mg l–1 similar to the empty vector control strain (130.0 ± 5.3 mg l–1) (Table 5). The cadaverine titers of 130.0 ± 5.3 mg l–1 achieved by MGA3_Cad are higher than the L-lysine titer of 37.8 ± 7.2 mg L–1 achieved by MGA3_EV in this study (Figure 2B). This is in accordance with previous findings of Nærdal et al. (2011, 2015) who attributed high cadaverine titers for production strain in relation to L-lysine titer in empty vector control strain to a metabolic pull which deregulated flux through the L-lysine biosynthesis pathway.

TABLE 5.

Growth rates, enzyme activities and L-lysine, cadaverine, and 5AVA final titers accumulated in growth media of recombinant MGA3 strains.

Strain Growth rate [h–1] Coupled activity of PatAD or Puo-PatD [mU mg–1] Lysine [mg l–1] Cadaverine [mg l–1] 5AVA [mg l–1]
MGA3_Cad 0.37 ± 0.01 0 ± 0 Not detected 123.0 ± 5.3 0.0 ± 0.0
MGA3_SpuI 0.33 ± 0.01 N.A. Not detected 118.82 ± 5.1 0.0 ± 0.0
MGA3_PatAEc 0.12 ± 0.02 7 ± 4 Not detected 1.47 ± 0.17 23.7 ± 2.7
MGA3_PatABm 0.15 ± 0.03 170 ± 37 Not detected 0.71 ± 0.11 8.3 ± 4.1
MGA3_Cad 0.35 ± 0.01 0 ± 0 Not detected Supplemented (500 mg L–1) 0.0 ± 0.0
MGA3_SpuI 0.32 ± 0.00 N.A. Not detected Supplemented (500 mg L–1) 0.0 ± 0.0
MGA3_PatAEc 0.14 ± 0.02 7 ± 4 Not detected Supplemented (500 mg L–1) 31.8 ± 2.3
MGA3_PatABm 0.17 ± 0.04 170 ± 37 Not detected Supplemented (500 mg L–1) 77.7 ± 5.5
MGA3_Kat 0.32 ± 0.00 0 ± 0 3.1 ± 0.5 Supplemented (500 mg L–1) 0.0 ± 0.0
MGA3_PuoEc 0.28 ± 0.01 0 ± 0 5.0 ± 0.7 Supplemented (500 mg L–1) 0.0 ± 0.0
MGA3_PuoPa 0.29 ± 0.01 0 ± 0 4.9 ± 0.9 Supplemented (500 mg L–1) 0.0 ± 0.0
MGA3_PuoRq 0.29 ± 0.00 0 ± 0 3.7 ± 0.2 Supplemented (500 mg L–1) 0.0 ± 0.0

The B. methanolicus strains expressing pathways that use cadaverine as an intermediate (SpuI, PatA, or Puo pathways) were cultivated for 24 h, and supernatants were obtained by centrifugation for HPLC analysis. Catalytic activities of PatA and PatD or Puo and PatD were measured by using a coupled reaction, and cadaverine was used as substrate (see Section “Enzyme Assays”). The standard deviation of technical triplicates is shown. NB: RaiP activity and 5AVA production for the RaiP pathway is shown Figure 2.

The PatA Pathway Supports 5AVA Accumulation in B. methanolicus

In the next step, two versions of the PatA pathway (Figure 1D) derived from either E. coli or B. megaterium were tested in strains MGA3(pTH1mp-cadA)(pBV2xp-AVAEc) named MGA3_PatAEc and MGA3(pTH1mp-cadA)(pBV2xp-AVABm) named MGA3 _PatABm (Table 4), respectively. The optimal temperature of PatA derived from E. coli is 60°C, which means that it is a thermostable enzyme that should be active at 50°C, which is a temperature used for the production experiment. PatA was shown to have a broad substrate range including cadaverine and, in lower extent, spermidine, but not ornithine (Samsonova et al., 2003). This property was used by Jorge et al. (2017) who have shown in their study that it is possible to use PatA and PatD derived from E. coli to establish conversion of cadaverine to 5AVA, confirming experimentally the broad substrate range of those two enzymes. The B. megaterium-derived PatA was characterized only superficially with regard to its substrate spectrum and not optimal temperature or thermostability (Slabu et al., 2016); however, its host organism is known to have a wide temperature range for growth up to 45°C (Vary et al., 2007). The multiple-sequence alignment with E. coli-derived enzymes showed identity of 63 and 38% for PatA and PatD, respectively (Okada et al., 1979). Both E. coli and B. megaterium-derived versions of the pathway are functional in B. methanolicus, with the combined PatAD activity of 7 ± 4 mU and 170 ± 37 mU mg–1 (Table 5). Final 5AVA titers of 23.7 ± 2.7 and 8.3 ± 4.1 mg L–1 (Table 5) were achieved, which is considerably lower than 5AVA titers of 0.9 g l–1 obtained by wild-type C. glutamicum strain transformed with plasmids for expression of ldcC (coding for lysine decarboxylase) and patDA (Jorge et al., 2017). For both producer strains, the concentration of unconverted cadaverine is similar: 1.7 ± 0.1 mg l–1 and 1.5 ± 0.2 mg l–1 for MGA3_PatAEc and MGA3_PatABm, respectively (Table 5). While Km for cadaverine has not been assessed, it has been shown to be 811 mg l–1 for putrescine for E. coli-derived PatA; assuming similar Km for cadaverine, it may explain why full conversion of cadaverine has not occurred (Samsonova et al., 2003). Due to relatively high Km for putrescine of PatA, we decided to test how supplementation with external cadaverine affects 5AVA accumulation. In fact, for both MGA3_PatAEc and MGA3_PatABm, 5AVA titers increased to 31.8 ± 2.3 and 77.7 ± 5.5, respectively, when the growth medium was supplemented with 500 mg l–1 cadaverine (Table 5). These results indicate that the enhancement of precursor supply is one potential target for subsequent metabolic engineering efforts to increase 5AVA titers. Another important consideration for activity of transaminase is availability of keto acid that acts as amino group acceptor. It was shown that E. coli and B. megaterium-derived PatA can use either pyruvate or 2-oxoglutarate as amino group acceptors (Slabu et al., 2016); the intracellular concentrations of those compounds in B. methanolicus MGA3 cells are 3.2 and 2.7 mM, respectively (Brautaset et al., 2003). Knowing that Km for 2-oxoglutarate for E. coli-derived PatA is 19.0 mM (Samsonova et al., 2003), recovery of the keto acids may be a limitation for 5AVA accumulation. This issue could be potentially solved by heterologous production of alanine dehydrogenase or L-glutamate oxidase which catalyzes reactions where pyruvate or 2-oxoglutarate is produced (Böhmer et al., 1989; Sakamoto et al., 1990; Slabu et al., 2016).

Use of the Puo Pathway Leads to 5AVA Production in B. methanolicus

Lastly, a pathway that relies on an activity of the monooxygenase putrescine oxidase (Puo, EC 1.4.3.10) was tested (Figure 1E). Puo catalyzes the oxidative deamination of cadaverine in lieu of cadaverine transamination catalyzed by PatA. It was shown that different putrescine oxidases can use cadaverine as their substrate with 9–14% of their maximal activity shown when putrescine is a substrate (Desa, 1972; Okada et al., 1979; van Hellemond et al., 2008; Lee et al., 2013). Moreover, putrescine oxidases derived from K. rosea (Micrococcus rubens) and Rhodococcus are thermostable and optimal activity of P. aurescens-derived Puo is at 50°C (Desa, 1972; van Hellemond et al., 2008; Lee et al., 2013). The disadvantage of this pathway is that it requires O2, the supply of which may be difficult to control. Furthermore, due to formation of hydrogen peroxide in the reaction catalyzed by Puo, the oxidative stress may increase when this pathway is active. In order to avoid detrimental effect of hydrogen peroxide accumulation, catalase was overproduced in the recombinant strains containing the Puo pathway: MGA3(pTH1mp-katA)(pBV2xp-AVAKr) named MGA3_PuoKr, MGA3(pTH1mp-katA)(pBV2xp AVAPa) named MGA3_PuoPa, and MGA3(pTH1mp-katA)(pBV2xp-AVARq) named MGA3_PuoRq (Table 4). To achieve sufficient levels of the pathway precursor, cadaverine, we have decided not to rely on plasmid-based production of lysine decarboxylase and to add cadaverine to the growth medium, instead. The tested recombinant strains with the Puo pathway did not produce 5AVA, which is consistent with no Puo-PatD activity detected in crude extracts (Table 5). The Puo pathway was shown to be active in C. glutamicum where titer of 0.1 ± 0.0–0.4 ± 0.0 g l–1 5AVA was achieved (Haupka et al., 2020).

Conclusion

In the search for 5AVA production from the sustainable feedstock methanol, we have screened five pathways toward 5AVA biosynthesis in B. methanolicus. No 5AVA production was observed for DavBA, Puo, and SpuI pathways. However, the pathways relying on RaiP and PatA activities were functional in shake flask cultures of B. methanolicus, which led to 5AVA production from methanol for the first time, respectively, up to 16.15 ± 1.62 mg l–1 or 23.7 ± 2.7. RaiP and PatA pathways are targets for further optimizations which could increase the 5AVA titers in the constructed strains. For instance, the improvement of substrate utilization and H2O2 availability or decomposition efficiency might contribute to the increase in the yield of 5AVA. Moreover, our study shows that the availability of supplemented cadaverine has high impact on 5AVA titer when the PatA pathway is employed. Another factor that needs to be considered is tolerance to 5AVA, which was shown to be low (Haupka et al., 2021). Recently, adaptative laboratory evolution experiments resulted in the selection of a mutant strain of B. methanolicus that displays tolerance to approximately 46 g l–1 5AVA (Haupka et al., 2021), which could be employed as a platform to develop high-titer 5AVA production strains. This shows that methanol has the potential to become a sustainable feedstock for the production of 5AVA.

Data Availability Statement

The original contributions generated for this study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Author Contributions

LB, MI, IN, and SL: study design and experimental work. BD: bioinformatic analysis. LB and MI: writing—original draft preparation. TB: writing—review and editing and project administration. SH, TB, MI, and IN: funding acquisition. All authors have read and agreed to the published version of the manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank Tonje Marita Bjerkan Heggeset from SINTEF Industry for technical assistance.

Footnotes

Funding. This research was funded by The Research Council of Norway within ERA CoBioTech, an ERA-Net Cofund Action under H2020, grant number 285794 ERA-NET.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fbioe.2021.686319/full#supplementary-material

References

  1. Adkins J., Jordan J., Nielsen D. R. (2013). Engineering Escherichia coli for renewable production of the 5-carbon polyamide building-blocks 5-aminovalerate and glutarate. Biotechnol. Bioeng. 110 1726–1734. 10.1002/bit.24828 [DOI] [PubMed] [Google Scholar]
  2. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. (1990). Basic local alignment search tool. J. Mol. Biol. 215 403–410. 10.1016/S0022-2836(05)80360-2 [DOI] [PubMed] [Google Scholar]
  3. Arinbasarova A. Y., Ashin V. V., Makrushin K. V., Medentsev A. G., Lukasheva E. V., Berezov T. T. (2012). Isolation and properties of L-lysine-α-oxidase from the fungus Trichoderma cf. aureoviride RIFAI VKM F-4268D. Microbiology 81 549–554. 10.1134/S0026261712050037 [DOI] [PubMed] [Google Scholar]
  4. Böhmer A., Müller A., Passarge M., Liebs P., Honeck H., Müller H.-G. (1989). A novel L-glutamate oxidase from Streptomyces endus. Eur. J. Biochem. 182 327–332. 10.1111/j.1432-1033.1989.tb14834.x [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 248–254. 10.1006/abio.1976.9999 [DOI] [PubMed] [Google Scholar]
  6. Brautaset T., Jakobsen Ø. M., Degnes K. F., Netzer R., Nśrdal I., Krog A., et al. (2010). Bacillus methanolicus pyruvate carboxylase and homoserine dehydrogenase I and II and their roles for L-lysine production from methanol at 50°C. Appl. Microbiol. Biotechnol. 87 951–964. 10.1007/s00253-010-2559-6 [DOI] [PubMed] [Google Scholar]
  7. Brautaset T., Williams M. D., Dillingham R. D., Kaufmann C., Bennaars A., Crabbe E., et al. (2003). Role of the Bacillus methanolicus citrate synthase II gene, citY, in regulating the secretion of glutamate in L-lysine-secreting mutants. Appl. Microbiol. Biotechnol. 69 3986–3995. 10.1128/AEM.69.7.3986-3995.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cen X., Liu Y., Chen B., Liu D., Chen Z. (2021). Metabolic engineering of Escherichia coli for de novo production of 1,5-pentanediol from glucose. ACS Synth. Biol. 10 192–203. 10.1021/acssynbio.0c00567 [DOI] [PubMed] [Google Scholar]
  9. Chae T. U., Ko Y.-S., Hwang K.-S., Lee S. Y. (2017). Metabolic engineering of Escherichia coli for the production of four-, five- and six-carbon lactams. Metab. Eng. 41 82–91. 10.1016/j.ymben.2017.04.001 [DOI] [PubMed] [Google Scholar]
  10. Cheng J., Luo Q., Duan H., Peng H., Zhang Y., Hu J., et al. (2020). Efficient whole-cell catalysis for 5-aminovalerate production from L-lysine by using engineered Escherichia coli with ethanol pretreatment. Sci. Rep. 10:990. 10.1038/s41598-020-57752-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cheng J., Tu W., Luo Z., Gou X., Li Q., Wang D., et al. (2021). A high-efficiency artificial synthetic pathway for 5-aminovalerate production from biobased L-lysine in Escherichia coli. Front. Bioeng. Biotechnol. 9:633028. 10.3389/fbioe.2021.633028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cheng J., Zhang Y., Huang M., Chen P., Zhou X., Wang D., et al. (2018). Enhanced 5-aminovalerate production in Escherichia coli from L-lysine with ethanol and hydrogen peroxide addition. J. Chem. Technol. Biotechnol. 93 3492–3501. 10.1002/jctb.5708 [DOI] [Google Scholar]
  13. Cotton C. A., Claassens N. J., Benito-Vaquerizo S., Bar-Even A. (2020). Renewable methanol and formate as microbial feedstocks. Curr. Opin. Biotechnol. 62 168–180. 10.1016/j.copbio.2019.10.002 [DOI] [PubMed] [Google Scholar]
  14. Delépine B., Duigou T., Carbonell P., Faulon J. L. (2018). RetroPath2.0: a retrosynthesis workflow for metabolic engineers. Metab. Eng. 45 158–170. 10.1016/j.ymben.2017.12.002 [DOI] [PubMed] [Google Scholar]
  15. Desa R. J. (1972). Putrescine oxidase from Micrococcus rubens. J. Biol. Chem. 247 5527–5534. 10.1016/s0021-9258(20)81137-5 [DOI] [PubMed] [Google Scholar]
  16. Drejer E. B., Chan D. T. C., Haupka C., Wendisch V. F., Brautaset T., Irla M. (2020). Methanol-based acetoin production by genetically engineered Bacillus methanolicus. Green Chem. 22 788–802. 10.1039/c9gc03950c [DOI] [Google Scholar]
  17. Duigou T., Du Lac M., Carbonell P., Faulon J. L. (2019). Retrorules: a database of reaction rules for engineering biology. Nucleic Acids Res. 47 D1229–D1235. 10.1093/nar/gky940 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Eikmanns B. J., Thum-schmitz N., Eggeling L., Ludtke K., Sahm H. (1994). Nucleotide sequence, expression and transcriptional analysis of the Corynebacterium glutamicum gltA gene encoding citrate synthase. Microbiology 140 1817–1828. 10.1099/13500872-140-8-1817 [DOI] [PubMed] [Google Scholar]
  19. Fortina M. G., Mora D., Schumann P., Parini C., Manachini P. L., Stackebrandt E. (2001). Reclassification of Saccharococcus caldoxylosilyticus as Geobacillus caldoxylosilyticus (Ahmad et al. 2000) comb. nov. Int. J. Syst. Evol. Microbiol. 51(Pt 6) 2063–2071. 10.1099/00207713-51-6-2063 [DOI] [PubMed] [Google Scholar]
  20. Gibson D., Young L., Chuang R. Y., Venter J. C., Hutchison C. A., III, Smith H. O. (2009). Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6 343–345. 10.1038/nmeth.1318 [DOI] [PubMed] [Google Scholar]
  21. Green R., Rogers E. J. (2013). Transformation of chemically competent E. coli. Methods Enzymol. 529 329–336. 10.1016/B978-0-12-418687-3.00028-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Haas T., Poetter M., Pfeffer J. C., Kroutil W., Skerra A., Lerchner A., et al. (2014). Oxidation and Amination of Secondary Alcohols. Patent number EP2734631B1. Munich: European Patent Office. [Google Scholar]
  23. Haupka C., Delépine B., Irla M., Heux S., Wendisch V. F. (2020). Flux enforcement for fermentative production of 5-aminovalerate and glutarate by Corynebacterium glutamicum. Catalysts 10:1065. 10.3390/catal10091065 [DOI] [Google Scholar]
  24. Haupka C., Fernandes de Brito L., Busche T., Wibberg D., Wendisch V. F. (2021). Genomic and transcriptomic investigation of the physiological response of the methylotroph Bacillus methanolicus to 5-aminovalerate. Front. Microbiol. 12:664598. 10.3389/fmicb.2021.664598 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Heggeset T. M. B., Krog A., Balzer S., Wentzel A., Ellingsen T. E., Brautaset T. (2012). Genome sequence of thermotolerant Bacillus methanolicus: features and regulation related to methylotrophy and production of L-lysine and L-glutamate from methanol. Appl. Environ. Microbiol. 78 5170–5181. 10.1128/AEM.00703-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Irla M., Heggeset T. M. B., Nærdal I., Paul L., Haugen T., Le S. B., et al. (2016). Genome-based genetic tool development for Bacillus methanolicus: theta- and rolling circle-replicating plasmids for inducible gene expression and application to methanol-based cadaverine production. Front. Microbiol. 7:1481. 10.3389/fmicb.2016.01481 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Irla M., Nærdal I., Brautaset T., Wendisch V. F. (2017). Methanol-based γ-aminobutyric acid (GABA) production by genetically engineered Bacillus methanolicus strains. Ind. Crops Prod. 106 12–20. 10.1016/j.indcrop.2016.11.050 [DOI] [Google Scholar]
  28. Ishizuka H., Horinouchi S., Beppu T. (1993). Putrescine oxidase of Micrococcus rubens: primary structure and Escherichia coli. J. Gen. Microbiol. 139 425–432. 10.1099/00221287-139-3-425 [DOI] [PubMed] [Google Scholar]
  29. Jakobsen Ø. M., Benichou A., Flickinger M. C., Valla S., Ellingsen T. E., Brautaset T. (2006). Upregulated transcription of plasmid and chromosomal ribulose monophosphate pathway genes is critical for methanol assimilation rate and methanol tolerance in the methylotrophic bacterium Bacillus methanolicus. J. Bacteriol. 188 3063–3072. 10.1128/JB.188.8.3063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Jakobsen Ø. M., Brautaset T., Degnes K. F., Heggeset T. M. B., Balzer S., Flickinger M. C., et al. (2009). Overexpression of wild-type aspartokinase increases L-lysine production in the thermotolerant methylotrophic bacterium Bacillus methanolicus. Appl. Environ. Microbiol. 75 652–661. 10.1128/AEM.01176-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Job V., Marcone G. L., Pilone M. S., Pollegioni L. (2002). Glycine oxidase from Bacillus subtilis: characterization of a new flavoprotein. J. Biol. Chem. 277 6985–6993. 10.1074/jbc.M111095200 [DOI] [PubMed] [Google Scholar]
  32. Joo J. C., Oh Y. H., Yu J. H., Hyun S. M., Khang T. U., Kang K. H., et al. (2017). Production of 5-aminovaleric acid in recombinant Corynebacterium glutamicum strains from a Miscanthus hydrolysate solution prepared by a newly developed Miscanthus hydrolysis process. Bioresour. Technol. 245 1692–1700. 10.1016/j.biortech.2017.05.131 [DOI] [PubMed] [Google Scholar]
  33. Jorge J. M. P., Pérez-García F., Wendisch V. F. (2017). A new metabolic route for the fermentative production of 5-aminovalerate from glucose and alternative carbon sources. Bioresour. Technol. 245 1701–1709. 10.1016/j.biortech.2017.04.108 [DOI] [PubMed] [Google Scholar]
  34. Kusakabe H., Kodama K., Kuninaka A., Yoshino H., Misono H., Soda K. (1980). A new antitumor enzyme, L-lysine alpha-oxidase from Trichoderma viride. Purification and enzymological properties. J. Biol. Chem. 255 976–981. 10.1016/S0021-9258(19)86128-8 [DOI] [PubMed] [Google Scholar]
  35. Lee J.-I., Jang J.-H., Yu M.-J., Kim Y.-W. (2013). Construction of a bifunctional enzyme fusion for the combined determination of biogenic amines in foods. J. Agric. Food Chem. 61 9118–9124. 10.1021/jf403044m [DOI] [PubMed] [Google Scholar]
  36. Lee J. I., Kim Y. W. (2013). Characterization of amine oxidases from Arthrobacter aurescens and application for determination of biogenic amines. World J. Microbiol. Biotechnol. 29 673–682. 10.1007/s11274-012-1223-y [DOI] [PubMed] [Google Scholar]
  37. Liu H., Naismith J. H. (2008). An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol. BMC Biotechnol. 8:91. 10.1186/1472-6750-8-91 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Liu P., Zhang H., Lv M., Hu M., Li Z., Gao C., et al. (2014). Enzymatic production of 5-aminovalerate from L-lysine using L-lysine monooxygenase and 5-aminovaleramide amidohydrolase. Sci. Rep. 4:5657. 10.1038/srep05657 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Luengo J. M., Olivera E. R. (2020). Catabolism of biogenic amines in Pseudomonas species. Environ. Microbiol. 22 1174–1192. 10.1111/1462-2920.14912 [DOI] [PubMed] [Google Scholar]
  40. Mai-Prochnow A., Lucas-Elio P., Egan S., Thomas T., Webb J. S., Sanchez-Amat A., et al. (2008). Hydrogen peroxide linked to lysine oxidase activity facilitates biofilm differentiation and dispersal in several Gram-negative bacteria. J. Bacteriol. 190 5493–5501. 10.1128/JB.00549-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Moretti S., Martin O., van Du Tran T., Bridge A., Morgat A., Pagni M. (2016). MetaNetX/MNXref - reconciliation of metabolites and biochemical reactions to bring together genome-scale metabolic networks. Nucleic Acids Res. 44 D523–D526. 10.1093/nar/gkv1117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Nærdal I., Netzer R., Ellingsen T. E., Brautaset T. (2011). Analysis and manipulation of aspartate pathway genes for L-lysine overproduction from methanol by Bacillus methanolicus. Appl. Environ. Microbiol. 77 6020–6026. 10.1128/AEM.05093-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nærdal I., Netzer R., Irla M., Krog A., Heggeset T. M. B., Wendisch V. F., et al. (2017). L-lysine production by Bacillus methanolicus: genome-based mutational analysis and L-lysine secretion engineering. J. Biotechnol. 244 25–33. 10.1016/j.jbiotec.2017.02.001 [DOI] [PubMed] [Google Scholar]
  44. Nærdal I., Pfeifenschneider J., Brautaset T., Wendisch V. F. (2015). Methanol-based cadaverine production by genetically engineered Bacillus methanolicus strains. Microb. Biotechnol. 8 342–350. 10.1111/1751-7915.12257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Noor E., Bar-Even A., Flamholz A., Lubling Y., Davidi D., Milo R. (2012). An integrated open framework for thermodynamics of reactions that combines accuracy and coverage. Bioinformatics 28 2037–2044. 10.1093/bioinformatics/bts317 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Okada M., Kawashima S., Imahori K. (1979). Substrate specificity and reaction mechanism of putrescine oxidase. J. Biochem. 86 97–104. [PubMed] [Google Scholar]
  47. Orth J. D., Conrad T. M., Na J., Lerman J. A., Nam H., Feist A. M., et al. (2011). A comprehensive genome-scale reconstruction of Escherichia coli metabolism-2011. Mol. Syst. Biol. 7:535. 10.1038/msb.2011.65 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Park S. J., Kim E. Y., Noh W., Park H. M., Oh Y. H., Lee S. H., et al. (2013). Metabolic engineering of Escherichia coli for the production of 5-aminovalerate and glutarate as C5 platform chemicals. Metab. Eng. 16 42–47. 10.1016/j.ymben.2012.11.011 [DOI] [PubMed] [Google Scholar]
  49. Park S. J., Oh Y. H., Noh W., Kim H. Y., Shin J. H., Lee E. G., et al. (2014). High-level conversion of L-lysine into 5-aminovalerate that can be used for nylon 6,5 synthesis. Biotechnol. J. 9 1322–1328. 10.1002/biot.201400156 [DOI] [PubMed] [Google Scholar]
  50. Pérez-García F., Jorge J. M. P., Dreyszas A., Risse J. M., Wendisch V. F. (2018). Efficient production of the dicarboxylic acid glutarate by Corynebacterium glutamicum via a novel synthetic pathway. Front. Microbiol. 9:2589. 10.3389/fmicb.2018.02589 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Revelles O., Espinosa-Urgel M., Fuhrer T., Sauer U., Ramos J. L. (2005). Multiple and interconnected pathways for L-lysine catabolism in Pseudomonas putida KT2440. J. Bacteriol. 187 7500–7510. 10.1128/JB.187.21.7500-7510.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Rohles C. M., Gießelmann G., Kohlstedt M., Wittmann C., Becker J. (2016). Systems metabolic engineering of Corynebacterium glutamicum for the production of the carbon-5 platform chemicals 5-aminovalerate and glutarate. Microb. Cell Fact. 15:154. 10.1186/s12934-016-0553-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Sakamoto Y., Nagata S., Esaki N., Tanaka H., Soda K. (1990). Gene cloning, purification and characterization of thermostable alanine dehydrogenase of Bacillus stearothermophilus. J. Ferment. Bioeng. 69 154–158. 10.1016/0922-338X(90)90038-X [DOI] [Google Scholar]
  54. Sambrook J., Russell D. W. (2001). Molecular Cloning: A Laboratory Manual, 3rd Edn. Cold Spring Harbor, NY: Cold Spring Laboratory Press. [Google Scholar]
  55. Samsonova N. N., Smirnov S. V., Altman I. B., Ptitsyn L. R. (2003). Molecular cloning and characterization of Escherichia coli K12 ygjG gene. BMC Microbiol. 3:2. 10.1186/1471-2180-3-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Schendel F. J., Bremmon C. E., Flickinger M. C., Guettler M. (1990). L-lysine production at 50°C by mutants of a newly isolated and characterized methylotrophic Bacillus sp. Appl. Environ. Microbiol. 56 963–970. 10.1128/AEM.56.4.963-970.1990 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Shin J. H., Park S. H., Oh Y. H., Choi J. W., Lee M. H., Cho J. S., et al. (2016). Metabolic engineering of Corynebacterium glutamicum for enhanced production of 5-aminovaleric acid. Microb. Cell Fact. 15:174. 10.1186/s12934-016-0566-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Slabu I., Galman J. L., Weise N. J., Lloyd R. C., Turner N. J. (2016). Putrescine transaminases for the synthesis of saturated nitrogen heterocycles from polyamines. ChemCatChem 8 1038–1042. 10.1002/cctc.201600075 [DOI] [Google Scholar]
  59. So J. H., Lim Y. M., Kim S. J., Kim H. H., Rhee I. K. (2013). Co-expression of gamma-aminobutyrate aminotransferase and succinic semialdehyde dehydrogenase genes for the enzymatic analysis of gamma-aminobutyric acid in Escherichia coli. J. Appl. Biol. Chem. 56 89–93. 10.3839/jabc.2013.015 [DOI] [Google Scholar]
  60. Sohn Y. J., Kang M., Baritugo K.-A., Son J., Kang K. H., Ryu M.-H., et al. (2021). Fermentative high-level production of 5-hydroxyvaleric acid by metabolically engineered Corynebacterium glutamicum. ACS Sustain. Chem. Eng. 9 2523–2533. 10.1021/acssuschemeng.0c08118 [DOI] [Google Scholar]
  61. Tani Y., Miyake R., Yukami R., Dekishima Y., China H., Saito S., et al. (2015a). Functional expression of L-lysine α-oxidase from Scomber japonicus in Escherichia coli for one-pot synthesis of L-pipecolic acid from DL-lysine. Appl. Microbiol. Biotechnol. 99 5045–5054. 10.1007/s00253-014-6308-0 [DOI] [PubMed] [Google Scholar]
  62. Tani Y., Omatsu K., Saito S., Miyake R., Kawabata H., Ueda M., et al. (2015b). Heterologous expression of L-lysine α-oxidase from Scomber japonicus in Pichia pastoris and functional characterization of the recombinant enzyme. J. Biochem. 157 201–210. 10.1093/jb/mvu064 [DOI] [PubMed] [Google Scholar]
  63. van Hellemond E. W., van Dijk M., Heuts D. P. H. M., Janssen D. B., Fraaije M. W. (2008). Discovery and characterization of a putrescine oxidase from Rhodococcus erythropolis NCIMB 11540. Appl. Microbiol. Biotechnol. 78 455–463. 10.1007/s00253-007-1310-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Vary P. S., Biedendieck R., Fuerch T., Meinhardt F., Rohde M., Deckwer W.-D., et al. (2007). Bacillus megaterium-from simple soil bacterium to industrial protein production host. Appl. Microbiol. Biotechnol. 76 957–967. 10.1007/s00253-007-1089-3 [DOI] [PubMed] [Google Scholar]
  65. Wang X., Cai P., Chen K., Ouyang P. (2016). Efficient production of 5-aminovalerate from L-lysine by engineered Escherichia coli whole-cell biocatalysts. J. Mol. Catal. B Enzym. 134 115–121. 10.1016/j.molcatb.2016.10.008 [DOI] [Google Scholar]
  66. Wendisch V. F. (2020). Metabolic engineering advances and prospects for amino acid production. Metab. Eng. 58 17–34. 10.1016/j.ymben.2019.03.008 [DOI] [PubMed] [Google Scholar]
  67. Wendisch V. F., Mindt M., Pérez-García F. (2018). Biotechnological production of mono- and diamines using bacteria: recent progress, applications, and perspectives. Appl. Microbiol. Biotechnol. 102 3583–3594. 10.1007/s00253-018-8890-z [DOI] [PubMed] [Google Scholar]
  68. Yao X., He W., Lu C. D. (2011). Functional characterization of seven γ-glutamylpolyamine synthetase genes and the bauRABCD locus for polyamine and β-alanine utilization in Pseudomonas aeruginosa PAO1. J. Bacteriol. 193 3923–3930. 10.1128/JB.05105-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Yumoto I., Hirota K., Yamaga S., Nodasaka Y., Kawasaki T., Matsuyama H., et al. (2004). Bacillus asahii sp. nov., a novel bacterium isolated from soil with the ability to deodorize the bad smell generated from short-chain fatty acids. Int. J. Syst. Evol. Microbiol. 54 1997–2001. 10.1099/ijs.0.03014-0 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

The original contributions generated for this study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.


Articles from Frontiers in Bioengineering and Biotechnology are provided here courtesy of Frontiers Media SA

RESOURCES